Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
03/04/2004 | WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces |
03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
03/04/2004 | WO2002092762A3 Cytokine polypeptides |
03/04/2004 | WO2002036158A8 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
03/04/2004 | US20040044194 Aggrecanase molecules |
03/04/2004 | US20040044061 Analgesics; side effect reduction |
03/04/2004 | US20040044051 Cannabinoid receptor agonists |
03/04/2004 | US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
03/04/2004 | US20040044038 Polymorphic form XVI of fexofenadine hydrochloride |
03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
03/04/2004 | US20040044035 Antiallergens; rhinitis |
03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
03/04/2004 | US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists |
03/04/2004 | US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
03/04/2004 | US20040043999 Phthalazine derivatives as phosphodiesterase 4-inhibitors |
03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
03/04/2004 | US20040043375 Regulation of human serine-threonine protein kinase |
03/04/2004 | US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution |
03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
03/04/2004 | CA2496573A1 Agent for prevention and/or treatment of asthma |
03/04/2004 | CA2495689A1 Pharmaceutical compositions |
03/04/2004 | CA2495603A1 Benzonaphthyridines with pde 3/4 inhibiting activity |
03/04/2004 | CA2495597A1 Novel phenanthridines |
03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
03/04/2004 | CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors |
03/04/2004 | CA2494643A1 Piperidine-n-oxide-derivatives |
03/04/2004 | CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
03/03/2004 | EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease |
03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
03/03/2004 | EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
03/03/2004 | EP1392823A2 Desaturase genes and uses thereof |
03/03/2004 | EP1392729A2 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhalation devices and method of diagnosis |
03/03/2004 | EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
03/03/2004 | EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives |
03/03/2004 | EP1392687A1 1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
03/03/2004 | EP1392655A2 Potassium channel openers |
03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
03/03/2004 | EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
03/03/2004 | EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
03/03/2004 | EP1392274A1 Improved dosage form of n-acetyl cysteine |
03/03/2004 | EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same |
03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
03/03/2004 | EP1196440B1 Therapeutic peptides derived from subsequences of bpi |
03/03/2004 | EP1109571B1 Methods of treating salt-dependent hypertension |
03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
03/03/2004 | EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin |
03/03/2004 | EP0865430B1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
03/03/2004 | EP0738268B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
03/03/2004 | CN1479749A Polysaccharide compound having immune stimulating activity |
03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
03/03/2004 | CN1479625A Herbal pharmaceutical compositions for treating immun logical disorders |
03/03/2004 | CN1478783A Inositol polyphosphate ester derivative and its using method |
03/03/2004 | CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
03/03/2004 | CN1478545A Use of compound interferon in the treating of SARS disease |
03/03/2004 | CN1478522A Chinese medicine for treating chronic nasitis and its production method |
03/03/2004 | CN1478520A Heat-clearing and detoxic medicine and its preparation method |
03/03/2004 | CN1478494A Oral liquid for treating cough and asthma |
03/03/2004 | CN1478477A Pectoral |
03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
03/02/2004 | US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders |
03/02/2004 | US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors |
03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
03/02/2004 | US6699893 Glucocorticoid receptor modulators |
03/02/2004 | US6699888 Antiinflammatory |
03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
03/02/2004 | US6699846 Such as ischemia and reperfusion injury, using specified glycolipids structurally related to monophosphoryl lipid a but with reduced proinflammatory and pyrogenic activity |
03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |